|
시장보고서
상품코드
1906676
보인자 검사 서비스 시장 규모와 예측(2021-2031년) - 세계 및 지역별 점유율, 동향, 성장 기회 분석 보고서 : 유형별, 질환별, 최종사용자별, 지역별Carrier Testing Services Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Medical Condition, End User, and Geography |
||||||
보인자 검사 서비스 시장은 2024년 7억 9,119만 달러에서 2031년까지 23억 1,079만 달러에 이를 것으로 예측되고 있으며, 2025년부터 2031년에 걸쳐 CAGR 16.9%로 확대될 것으로 예측됩니다.
미국에서는 유전상담, 차세대염기서열분석(NGS), 유전자 검사(Carrier Screening Panel)의 이용이 표준이 되는 고도로 발달된 의료 시스템을 가지고 있습니다. Natera와 같은 검사기관 및 기업은 CLIA 인증 시설을 유지하고 있으며, 이를 통해 철저한 보인자 검사를 제공할 수 있습니다. 확대경 검진은 생식의학 분야뿐만 아니라 임신 전 관리와 산전 관리에서도 널리 받아들여지고 있습니다. 유전정보차별금지법(GINA) 등 윤리적, 규제적 조치가 시행되면서 유전정보 활용에 대한 우려가 완화되고 있습니다. 보인자 검사와 보조생식술의 연계가 심화되고 있으며, 일반적으로 체외수정(IVF)을 받는 부부나 가족 형성을 원하는 부부는 유전질환의 위험성을 파악하기 위해 보인자 검사를 선택합니다. 미국 시장은 경쟁이 치열하고 기술 주도형이며, 보균자 스크리닝을 통한 예방적-맞춤형 생식 의료의 발전이 이루어지고 있습니다.
비교 기업 분석에서는 제품 포트폴리오(제품 만족도, 제품 기능, 가용성), 최근 동향(인수합병, 신제품 출시 및 개선, 투자 및 자금 조달, 수상, 계약, 제휴 및 협력 관계, 인지도, 사업 확장), 지리적 입지를 기반으로 보인자 검사 서비스 시장을 평가 및 분류하여 의사결정을 돕고 경쟁상황에 대한 이해를 돕습니다. 본 보고서는 세계 보인자 검사 서비스 시장의 주요 업체들의 최근 주요 동향과 혁신에 대한 철저한 검증을 제공합니다. 주요 시장 기업으로는 Eurofins Scientific SE, Quest Diagnostics, Myriad Genetics, Illumina, Thermo Fisher Scientific, OPKO Health, Laboratory Corporation of America, Fullgent Genetics, MedGenetics, Gene by Gene 등이 있습니다.
유형별로는 보인자 검사 서비스 시장은 확장형 보인자 검사와 특정 질병 보인자 검사로 구분됩니다. 2024년에는 확장된 캐리어 스크리닝 부문이 더 큰 시장 점유율을 차지했습니다. 이는 업데이트된 임상 가이드라인, 혁신적인 제품 개발, 대규모 스크리닝 프로그램 도입 확대에 따른 급속한 성장이 견인하고 있으며, 보인자 검사 서비스 시장을 선도하고 있습니다.
질환별로는 폐질환, 혈액질환, 신경질환, 기타 질환으로 분류됩니다. 2024년 기준 폐 질환 부문이 보인자 검사 서비스 시장에서 가장 큰 점유율을 차지했습니다. 보인자 검사 시장에서 폐질환은 주로 유전성 폐질환을 의미하며, 그 중 낭포성 섬유증(CF)은 생식 환경에서 가장 흔한 유전성 호흡기 질환 중 하나입니다. CF는 생명을 위협하는 질환으로 평생에 걸친 집중적이고 고가의 치료가 필요하기 때문에 예비 부모님의 보균자 상태를 파악하는 것이 매우 중요합니다. 확장된 보균자 스크리닝(ECS) 패널은 대부분 CF 돌연변이를 보유하는 유전자를 포함하고 있기 때문에 이 질환이 이 부문의 주요 촉진제 역할을 하고 있습니다.
최종 사용자별로 보인자 검사 서비스 시장은 병원 내 검사실, 진단실험실, 기타 최종 사용자로 구분됩니다. 2024년에는 병원 내 검사실 부문이 큰 시장 점유율을 차지했습니다. 이는 신생아 유전자 검사 프로그램의 일상적인 시행, 유전성 질환에 대한 인식 증가, 그리고 어느 정도 유전적 요인을 가진 만성 질환 증가에 힘입어 급속한 성장을 이루었기 때문입니다.
보인자 검사 서비스 시장에서 사업을 전개하는 기업들은 다양한 유기적, 무기적 성장 전략을 채택하고 있습니다. 유기적 성장 전략으로는 주로 제품 출시와 제품 승인을 꼽을 수 있습니다. 시장에서 확인된 무기적 성장 전략에는 인수, 제휴, 파트너십 등이 있습니다. 이러한 성장 전략을 통해 시장 기업들은 사업 확장, 지리적 입지를 강화하여 전체 시장 성장에 기여하고 있습니다. 또한, 인수 및 파트너십을 통해 고객 기반을 강화하고 제품 포트폴리오를 확장하는 데 기여했습니다. 다음은 보인자 검사 서비스 시장의 주요 기업의 주요 개발 사항 중 일부를 소개합니다.
2025년 6월, Myriad Genetics는 대규모 임상연구에 기반한 'FirstGene Multiple Prenatal Screen'의 얼리 액세스 제공을 시작했습니다.
2025년 3월, 바이오테크네 산하 아슬라젠은 옥스포드 나노포어 테크놀로지스(Oxford Nanopore Technologies)와 제휴하여 연구용 캐리어 스크리닝을 위한 'AmplideX 나노포어 캐리어 플러스 키트'를 출시하였습니다.
2024년 8월, 랩코프는 인비테아의 특정 자산 인수를 완료하여 종양학 및 희귀질환 유전자 검사 분야의 리더십을 강화하고 기존 서비스에 고급 유전자 검사 기능을 통합했습니다.
목차
제1장 도입
제2장 주요 요약
- 애널리스트 시장 전망
- 시장의 매력
제3장 조사 방법
- 2차 조사
- 1차 조사
- 가설 책정
- 거시경제적 요인 분석
- 기준치 산출
- 데이터 삼각측량
- 국가 레벨 데이터
- 전제조건과 제한 사항
제4장 보인자 검사 서비스 시장 구도
- PEST 분석
- 생태계 분석
- 밸류체인 벤더 리스트
제5장 보인자 검사 서비스 시장 - 주요 시장 역학
- 보인자 검사 서비스 시장 - 주요 시장 역학
- 시장 성장 촉진요인
- 시장 성장 억제요인
- 시장 기회
- 향후 동향
- 성장 촉진요인과 억제요인의 영향
제6장 보인자 검사 서비스 시장 - 세계 시장 분석
- 보인자 검사 서비스 시장 매출(2021년-2031년)
- 보인자 검사 서비스 시장 예측 분석
제7장 보인자 검사 서비스 시장 분석 - 유형별
- 확장 캐리어 스크리닝
- 특정 질환 대상 캐리어 스크리닝
제8장 의료 상태 별 보인자 검사 서비스 시장 분석
- 폐 질환
- 혈액 질환
- 신경 질환
- 기타 질환
제9장 보인자 검사 서비스 시장 분석 - 최종사용자별
- 병원내 검사실
- 진단실험실
- 기타 최종사용자
제10장 보인자 검사 서비스 시장 - 지역 분석
- 북미
- 미국
- 캐나다
- 멕시코
- 유럽
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 기타 유럽
- 아시아태평양
- 중국
- 일본
- 인도
- 호주
- 한국
- 아시아태평양 기타 국가
- 중동 및 아프리카
- 사우디아라비아
- 남아프리카공화국
- 아랍에미리트(UAE)
- 기타 중동 및 아프리카
- 남미 및 중남미
- 브라질
- 아르헨티나
- 기타 남미·중앙아메리카
제11장 경쟁 구도
- 주요 기업별 히트맵 분석
- 기업 점유율 분석(2024년)
제12장 업계 상황
- 시장 이니셔티브
- 기타 동향
제13장 기업 개요
- Eurofins Scientific SE
- Quest Diagnostics Inc
- Myriad Genetics Inc
- Illumina, Inc
- Thermo Fisher Scientific Inc.
- Laboratory Corp of America Holdings
- Fulgent Genetics, Inc
- MedGenome Inc
- Gene By Gene Ltd
- F. Hoffmann-La Roche Ltd
제14장 부록
LSH 26.01.22The carrier testing services market is projected to reach US$ 2,310.79 million by 2031 from US$ 791.19 million in 2024. The market is projected to register a CAGR of 16.9% from 2025 to 2031. Major factors driving market growth include the rising prevalence of genetic diseases, increasing focus on personalized/preventive healthcare, and favorable government & regulatory support. They are propelling the acceptance of carrier testing services. Furthermore, the surging demand for personalized and home healthcare devices is expected to drive market growth during the forecast period. However, the high cost of genetic testing services, the social and ethical implications of carrier testing services, limited access to genetic counsellors, and interpretation challenges are among the market deterrents.
In the US, the nation boasts a well-developed healthcare system where the use of genetic counseling, next-generation sequencing (NGS), and carrier screening panels is the norm. Laboratories and companies, such as Natera, maintain CLIA-certified facilities, which enable them to provide thorough carrier tests. Expanded carrier screening is widely accepted in reproductive medicine as well as in preconception and prenatal care. Ethical and regulatory measures, such as the Genetic Information Nondiscrimination Act (GINA), are implemented to alleviate concerns about the use of genetic data. There is a deepening connection between carrier testing and assisted reproduction. Generally, couples going through IVF or those wishing to build a family choose to do carrier tests to figure out the chance of inherited diseases. The US market is very competitive and technology-driven, and is making progress toward preventive and personalized reproductive health through carrier screening.
The comparative company analysis evaluates and categorizes the carrier testing services market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report thoroughly examines the recent significant developments and innovations by leading vendors in the global carrier testing services market. The key market players include Eurofins Scientific SE, Quest Diagnostics Inc., Myriad Genetics Inc., Illumina Inc., Thermo Fisher Scientific Inc., OPKO Health Inc., Laboratory Corp of America Holdings, Fulgent Genetics, Inc., MedGenome Inc., and Gene By Gene Ltd.
In terms of type, the carrier testing services market is segmented into expanded carrier screening and targeted disease carrier screening. The expanded carrier screening segment held a larger market share in 2024, owing to experiencing rapid growth, driven by updated clinical guidelines, innovative product developments, and the increasing adoption of large-scale screening programs, which is leading the carrier testing services market.
Based on medical condition, the carrier testing services market is categorized into pulmonary conditions, hematological conditions, neurological conditions, and other medical conditions. The pulmonary conditions segment accounted for the largest share of the carrier testing services market in 2024. Within the carrier testing market, pulmonary conditions primarily signify genetically caused lung diseases, among which are cystic fibrosis (CF), one of the most prevalent inherited respiratory disorders in the reproductive milieu. Because CF is a life-limiting disease and requires intensive, lifelong, and expensive care, it is essential to know the carrier status of the parents-to-be. Most of the time, expanded carrier screening (ECS) panels include genes that carry the CF mutation, which is why this condition is the primary driver for the segment.
Based on end-user, the carrier testing services market is segmented into hospital-based laboratories, diagnostic laboratories, and other end-users. The hospital-based laboratories segment held a larger market share in 2024, owing to experiencing rapid growth, driven by the implementation of newborn genetic screening programs becoming routine, an increased consciousness of hereditary diseases, and a rise in chronic illnesses, which, to a certain extent, are of genetic origin.
Companies operating in the carrier testing services market adopt various organic and inorganic strategies. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaborations, and partnerships. These growth strategies enable market players to expand their businesses, enhance their geographic presence, and contribute to overall market growth. Furthermore, acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. The following are a few significant developments by key players in the carrier testing services market.
In June 2025, Myriad Genetics Inc. announced the early access launch of its FirstGene Multiple Prenatal Screen, based on a large-scale clinical study.
In March 2025, Bio-Techne's Asuragen partnered with Oxford Nanopore Technologies to release the AmplideX Nanopore Carrier Plus Kit for research carrier screening.
In August 2024, LabCorp finalized the acquisition of select Invitae assets, thereby enhancing its leadership in genetic testing for oncology and rare diseases while integrating advanced genetic testing capabilities with its existing services.
Table Of Contents
1. Introduction
- 1.1 Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
- 2.1 Analyst Market Outlook
- 2.2 Market Attractiveness
3. Research Methodology
- 3.1 Secondary Research
- 3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
- 3.3 Assumptions and Limitations
4. Carrier Testing Services Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Carrier Testing Services Market - Key Market Dynamics
- 5.1 Carrier Testing Services Market - Key Market Dynamics
- 5.2 Market Drivers
- 5.2.1 Rising Prevalence of Genetic Diseases
- 5.2.2 Increasing Personalized / Preventive Healthcare Focus
- 5.2.3 Favorable Government and Regulatory Support
- 5.3 Market Restraints
- 5.3.1 High Cost of Genetic Testing Services
- 5.3.2 Social and Ethical Implications of Carrier Testing Services
- 5.3.3 Limited Access to Genetic Counsellors and Interpretation Challenges
- 5.4 Market Opportunities
- 5.4.1 Growth in Emerging Economies
- 5.4.2 Expanded Carrier Screening Adoption
- 5.4.3 Growth of At-Home Testing Kits
- 5.5 Future Trends
- 5.5.1 Increasing AI-Driven Variant Interpretation
- 5.5.2 Rising Technological Innovation of NGS and Bioinformatics
- 5.5.3 Surging Population Screening and Public Health Programs
- 5.6 Impact of Drivers and Restraints:
6. Carrier Testing Services Market - Global Market Analysis
- 6.1 Carrier Testing Services Market Revenue (US$ Million), 2021-2031
- 6.2 Carrier Testing Services Market Forecast Analysis
7. Carrier Testing Services Market Analysis - by Type
- 7.1 Expanded Carrier Screening
- 7.1.1 Overview
- 7.1.2 Expanded Carrier Screening: Carrier Testing Services Market - Revenue and Forecast to 2031 (US$ Million)
- 7.2 Targeted Disease Carrier Screening
- 7.2.1 Overview
- 7.2.2 Targeted Disease Carrier Screening: Carrier Testing Services Market - Revenue and Forecast to 2031 (US$ Million)
8. Carrier Testing Services Market Analysis - by Medical Conditions
- 8.1 Pulmonary Conditions
- 8.1.1 Overview
- 8.1.2 Pulmonary Conditions: Carrier Testing Services Market - Revenue and Forecast to 2031 (US$ Million)
- 8.2 Hematological Conditions
- 8.2.1 Overview
- 8.2.2 Hematological Conditions: Carrier Testing Services Market - Revenue and Forecast to 2031 (US$ Million)
- 8.3 Neurological Conditions
- 8.3.1 Overview
- 8.3.2 Neurological Conditions: Carrier Testing Services Market - Revenue and Forecast to 2031 (US$ Million)
- 8.4 Other Medical Conditions
- 8.4.1 Overview
- 8.4.2 Other Medical Conditions: Carrier Testing Services Market - Revenue and Forecast to 2031 (US$ Million)
9. Carrier Testing Services Market Analysis - by End User
- 9.1 Hospital-Based Laboratories
- 9.1.1 Overview
- 9.1.2 Hospital-Based Laboratories: Carrier Testing Services Market - Revenue and Forecast to 2031 (US$ Million)
- 9.2 Diagnostic Laboratories
- 9.2.1 Overview
- 9.2.2 Diagnostic Laboratories: Carrier Testing Services Market - Revenue and Forecast to 2031 (US$ Million)
- 9.3 Other End Users
- 9.3.1 Overview
- 9.3.2 Other End Users: Carrier Testing Services Market - Revenue and Forecast to 2031 (US$ Million)
10. Carrier Testing Services Market - Geographical Analysis
- 10.1 Overview
- 10.2 North America
- 10.2.1 North America Carrier Testing Services Market Overview
- 10.2.2 North America: Carrier Testing Services Market - Revenue, 2021-2031 (US$ Million)
- 10.2.3 North America: Carrier Testing Services Market Breakdown, by Type
- 10.2.3.1 North America: Carrier Testing Services Market - Revenue and Forecast Analysis - by Type
- 10.2.4 North America: Carrier Testing Services Market Breakdown, by Medical Conditions
- 10.2.4.1 North America: Carrier Testing Services Market - Revenue and Forecast Analysis - by Medical Conditions
- 10.2.5 North America: Carrier Testing Services Market Breakdown, by End User
- 10.2.5.1 North America: Carrier Testing Services Market - Revenue and Forecast Analysis - by End User
- 10.2.6 North America: Carrier Testing Services Market - Revenue and Forecast Analysis - by Country
- 10.2.6.1 North America: Carrier Testing Services Market - Revenue and Forecast Analysis - by Country
- 10.2.6.2 United States: Carrier Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 10.2.6.2.1 United States: Carrier Testing Services Market Breakdown, by Type
- 10.2.6.2.2 United States: Carrier Testing Services Market Breakdown, by Medical Conditions
- 10.2.6.2.3 United States: Carrier Testing Services Market Breakdown, by End User
- 10.2.6.3 Canada: Carrier Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 10.2.6.3.1 Canada: Carrier Testing Services Market Breakdown, by Type
- 10.2.6.3.2 Canada: Carrier Testing Services Market Breakdown, by Medical Conditions
- 10.2.6.3.3 Canada: Carrier Testing Services Market Breakdown, by End User
- 10.2.6.4 Mexico: Carrier Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 10.2.6.4.1 Mexico: Carrier Testing Services Market Breakdown, by Type
- 10.2.6.4.2 Mexico: Carrier Testing Services Market Breakdown, by Medical Conditions
- 10.2.6.4.3 Mexico: Carrier Testing Services Market Breakdown, by End User
- 10.3 Europe
- 10.3.1 Europe Carrier Testing Services Market Overview
- 10.3.2 Europe: Carrier Testing Services Market - Revenue, 2021-2031 (US$ Million)
- 10.3.3 Europe: Carrier Testing Services Market Breakdown, by Type
- 10.3.3.1 Europe: Carrier Testing Services Market - Revenue and Forecast Analysis - by Type
- 10.3.4 Europe: Carrier Testing Services Market Breakdown, by Medical Conditions
- 10.3.4.1 Europe: Carrier Testing Services Market - Revenue and Forecast Analysis - by Medical Conditions
- 10.3.5 Europe: Carrier Testing Services Market Breakdown, by End User
- 10.3.5.1 Europe: Carrier Testing Services Market - Revenue and Forecast Analysis - by End User
- 10.3.6 Europe: Carrier Testing Services Market - Revenue and Forecast Analysis - by Country
- 10.3.6.1 Europe: Carrier Testing Services Market - Revenue and Forecast Analysis - by Country
- 10.3.6.2 Germany: Carrier Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 10.3.6.2.1 Germany: Carrier Testing Services Market Breakdown, by Type
- 10.3.6.2.2 Germany: Carrier Testing Services Market Breakdown, by Medical Conditions
- 10.3.6.2.3 Germany: Carrier Testing Services Market Breakdown, by End User
- 10.3.6.3 United Kingdom: Carrier Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 10.3.6.3.1 United Kingdom: Carrier Testing Services Market Breakdown, by Type
- 10.3.6.3.2 United Kingdom: Carrier Testing Services Market Breakdown, by Medical Conditions
- 10.3.6.3.3 United Kingdom: Carrier Testing Services Market Breakdown, by End User
- 10.3.6.4 France: Carrier Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 10.3.6.4.1 France: Carrier Testing Services Market Breakdown, by Type
- 10.3.6.4.2 France: Carrier Testing Services Market Breakdown, by Medical Conditions
- 10.3.6.4.3 France: Carrier Testing Services Market Breakdown, by End User
- 10.3.6.5 Italy: Carrier Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 10.3.6.5.1 Italy: Carrier Testing Services Market Breakdown, by Type
- 10.3.6.5.2 Italy: Carrier Testing Services Market Breakdown, by Medical Conditions
- 10.3.6.5.3 Italy: Carrier Testing Services Market Breakdown, by End User
- 10.3.6.6 Spain: Carrier Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 10.3.6.6.1 Spain: Carrier Testing Services Market Breakdown, by Type
- 10.3.6.6.2 Spain: Carrier Testing Services Market Breakdown, by Medical Conditions
- 10.3.6.6.3 Spain: Carrier Testing Services Market Breakdown, by End User
- 10.3.6.7 Rest of Europe: Carrier Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 10.3.6.7.1 Rest of Europe: Carrier Testing Services Market Breakdown, by Type
- 10.3.6.7.2 Rest of Europe: Carrier Testing Services Market Breakdown, by Medical Conditions
- 10.3.6.7.3 Rest of Europe: Carrier Testing Services Market Breakdown, by End User
- 10.4 Asia Pacific
- 10.4.1 Asia Pacific Carrier Testing Services Market Overview
- 10.4.2 Asia Pacific: Carrier Testing Services Market - Revenue, 2021-2031 (US$ Million)
- 10.4.3 Asia Pacific: Carrier Testing Services Market Breakdown, by Type
- 10.4.3.1 Asia Pacific: Carrier Testing Services Market - Revenue and Forecast Analysis - by Type
- 10.4.4 Asia Pacific: Carrier Testing Services Market Breakdown, by Medical Conditions
- 10.4.4.1 Asia Pacific: Carrier Testing Services Market - Revenue and Forecast Analysis - by Medical Conditions
- 10.4.5 Asia Pacific: Carrier Testing Services Market Breakdown, by End User
- 10.4.5.1 Asia Pacific: Carrier Testing Services Market - Revenue and Forecast Analysis - by End User
- 10.4.6 Asia Pacific: Carrier Testing Services Market - Revenue and Forecast Analysis - by Country
- 10.4.6.1 Asia Pacific: Carrier Testing Services Market - Revenue and Forecast Analysis - by Country
- 10.4.6.2 China: Carrier Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 10.4.6.2.1 China: Carrier Testing Services Market Breakdown, by Type
- 10.4.6.2.2 China: Carrier Testing Services Market Breakdown, by Medical Conditions
- 10.4.6.2.3 China: Carrier Testing Services Market Breakdown, by End User
- 10.4.6.3 Japan: Carrier Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 10.4.6.3.1 Japan: Carrier Testing Services Market Breakdown, by Type
- 10.4.6.3.2 Japan: Carrier Testing Services Market Breakdown, by Medical Conditions
- 10.4.6.3.3 Japan: Carrier Testing Services Market Breakdown, by End User
- 10.4.6.4 India: Carrier Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 10.4.6.4.1 India: Carrier Testing Services Market Breakdown, by Type
- 10.4.6.4.2 India: Carrier Testing Services Market Breakdown, by Medical Conditions
- 10.4.6.4.3 India: Carrier Testing Services Market Breakdown, by End User
- 10.4.6.5 Australia: Carrier Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 10.4.6.5.1 Australia: Carrier Testing Services Market Breakdown, by Type
- 10.4.6.5.2 Australia: Carrier Testing Services Market Breakdown, by Medical Conditions
- 10.4.6.5.3 Australia: Carrier Testing Services Market Breakdown, by End User
- 10.4.6.6 South Korea: Carrier Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 10.4.6.6.1 South Korea: Carrier Testing Services Market Breakdown, by Type
- 10.4.6.6.2 South Korea: Carrier Testing Services Market Breakdown, by Medical Conditions
- 10.4.6.6.3 South Korea: Carrier Testing Services Market Breakdown, by End User
- 10.4.6.7 Rest of APAC: Carrier Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 10.4.6.7.1 Rest of APAC: Carrier Testing Services Market Breakdown, by Type
- 10.4.6.7.2 Rest of APAC: Carrier Testing Services Market Breakdown, by Medical Conditions
- 10.4.6.7.3 Rest of APAC: Carrier Testing Services Market Breakdown, by End User
- 10.5 Middle East and Africa
- 10.5.1 Middle East and Africa Carrier Testing Services Market Overview
- 10.5.2 Middle East and Africa: Carrier Testing Services Market - Revenue, 2021-2031 (US$ Million)
- 10.5.3 Middle East and Africa: Carrier Testing Services Market Breakdown, by Type
- 10.5.3.1 Middle East and Africa: Carrier Testing Services Market - Revenue and Forecast Analysis - by Type
- 10.5.4 Middle East and Africa: Carrier Testing Services Market Breakdown, by Medical Conditions
- 10.5.4.1 Middle East and Africa: Carrier Testing Services Market - Revenue and Forecast Analysis - by Medical Conditions
- 10.5.5 Middle East and Africa: Carrier Testing Services Market Breakdown, by End User
- 10.5.5.1 Middle East and Africa: Carrier Testing Services Market - Revenue and Forecast Analysis - by End User
- 10.5.6 Middle East and Africa: Carrier Testing Services Market - Revenue and Forecast Analysis - by Country
- 10.5.6.1 Middle East and Africa: Carrier Testing Services Market - Revenue and Forecast Analysis - by Country
- 10.5.6.2 Saudi Arabia: Carrier Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 10.5.6.2.1 Saudi Arabia: Carrier Testing Services Market Breakdown, by Type
- 10.5.6.2.2 Saudi Arabia: Carrier Testing Services Market Breakdown, by Medical Conditions
- 10.5.6.2.3 Saudi Arabia: Carrier Testing Services Market Breakdown, by End User
- 10.5.6.3 South Africa: Carrier Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 10.5.6.3.1 South Africa: Carrier Testing Services Market Breakdown, by Type
- 10.5.6.3.2 South Africa: Carrier Testing Services Market Breakdown, by Medical Conditions
- 10.5.6.3.3 South Africa: Carrier Testing Services Market Breakdown, by End User
- 10.5.6.4 United Arab Emirates: Carrier Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 10.5.6.4.1 United Arab Emirates: Carrier Testing Services Market Breakdown, by Type
- 10.5.6.4.2 United Arab Emirates: Carrier Testing Services Market Breakdown, by Medical Conditions
- 10.5.6.4.3 United Arab Emirates: Carrier Testing Services Market Breakdown, by End User
- 10.5.6.5 Rest of Middle East and Africa: Carrier Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 10.5.6.5.1 Rest of Middle East and Africa: Carrier Testing Services Market Breakdown, by Type
- 10.5.6.5.2 Rest of Middle East and Africa: Carrier Testing Services Market Breakdown, by Medical Conditions
- 10.5.6.5.3 Rest of Middle East and Africa: Carrier Testing Services Market Breakdown, by End User
- 10.6 South and Central America
- 10.6.1 South and Central America Carrier Testing Services Market Overview
- 10.6.2 South and Central America: Carrier Testing Services Market - Revenue, 2021-2031 (US$ Million)
- 10.6.3 South and Central America: Carrier Testing Services Market Breakdown, by Type
- 10.6.3.1 South and Central America: Carrier Testing Services Market - Revenue and Forecast Analysis - by Type
- 10.6.4 South and Central America: Carrier Testing Services Market Breakdown, by Medical Conditions
- 10.6.4.1 South and Central America: Carrier Testing Services Market - Revenue and Forecast Analysis - by Medical Conditions
- 10.6.5 South and Central America: Carrier Testing Services Market Breakdown, by End User
- 10.6.5.1 South and Central America: Carrier Testing Services Market - Revenue and Forecast Analysis - by End User
- 10.6.6 South and Central America: Carrier Testing Services Market - Revenue and Forecast Analysis - by Country
- 10.6.6.1 South and Central America: Carrier Testing Services Market - Revenue and Forecast Analysis - by Country
- 10.6.6.2 Brazil: Carrier Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 10.6.6.2.1 Brazil: Carrier Testing Services Market Breakdown, by Type
- 10.6.6.2.2 Brazil: Carrier Testing Services Market Breakdown, by Medical Conditions
- 10.6.6.2.3 Brazil: Carrier Testing Services Market Breakdown, by End User
- 10.6.6.3 Argentina: Carrier Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 10.6.6.3.1 Argentina: Carrier Testing Services Market Breakdown, by Type
- 10.6.6.3.2 Argentina: Carrier Testing Services Market Breakdown, by Medical Conditions
- 10.6.6.3.3 Argentina: Carrier Testing Services Market Breakdown, by End User
- 10.6.6.4 Rest of South and Central America: Carrier Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 10.6.6.4.1 Rest of South and Central America: Carrier Testing Services Market Breakdown, by Type
- 10.6.6.4.2 Rest of South and Central America: Carrier Testing Services Market Breakdown, by Medical Conditions
- 10.6.6.4.3 Rest of South and Central America: Carrier Testing Services Market Breakdown, by End User
11. Competitive Landscape
- 11.1 Heat Map Analysis by Key Players
- 11.2 Company Market Share Analysis, 2024
12. Industry Landscape
- 12.1 Overview
- 12.2 Market Initiative
- 12.3 Other Developments
13. Company Profiles
- 13.1 Eurofins Scientific SE
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
- 13.2 Quest Diagnostics Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
- 13.3 Myriad Genetics Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
- 13.4 Illumina, Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
- 13.5 Thermo Fisher Scientific Inc.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
- 13.6 Laboratory Corp of America Holdings
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
- 13.7 Fulgent Genetics, Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
- 13.8 MedGenome Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
- 13.9 Gene By Gene Ltd
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
- 13.10 F. Hoffmann-La Roche Ltd
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
- 14.1 About The Insight Partners
- 14.2 List of Abbreviations
